Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Hypera S.A.
  6. Summary
    HYPE3   BRHYPEACNOR0

HYPERA S.A.

(HYPE3)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Valores De Sao P…
07/27/2021 07/28/2021 07/29/2021 07/30/2021 08/02/2021 Date
35.4 36.2 36.48 35.65 37 Last
2338800 2486700 2414900 2081700 4922500 Volume
-2.34% +2.26% +0.77% -2.28% +3.79% Change
Estimated financial data (e)
Sales 2021 5 823 M 1 130 M 1 130 M
Net income 2021 1 513 M 294 M 294 M
Net Debt 2021 4 164 M 808 M 808 M
P/E ratio 2021 15,4x
Yield 2021 2,89%
Sales 2022 6 546 M 1 270 M 1 270 M
Net income 2022 1 625 M 315 M 315 M
Net Debt 2022 4 087 M 793 M 793 M
P/E ratio 2022 14,7x
Yield 2022 3,34%
Capitalization 23 385 M 4 569 M 4 537 M
EV / Sales 2021 4,73x
EV / Sales 2022 4,20x
Nbr of Employees 8 918
Free-Float 58,1%
More Financials
Company
Hypera SA, formerly Hypermarcas SA, is a Brazil-based company engaged in the pharmaceuticals sector. The Company’s major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa. The Branded Prescription unit also acts as... 
Sector
Pharmaceuticals
Calendar
08/19 | 08:00amPresentation
More about the company
Ratings of Hypera S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about HYPERA S.A.
07/29HYPERA S A : ESM - Management Proposal (amended)
PU
07/23Hypera S.A. Announces Consolidated Earnings Results for the Second Quarter an..
CI
07/23HYPERA S.A. : Ex-dividend day for
FA
07/13SANOFI : to Sell Eight Consumer Healthcare Brands in Latin America to Hypera Pha..
MT
07/08HYPERA S A : Company, Subsidiary and affiliates Form - June
PU
07/08HYPERA S A : Consolidated Form - June
PU
07/08Hypera S.A. signed an agreement to acquire Bio Brands Franchising Gestão de M..
CI
06/28HYPERA S A : Notice to Shareholders - Dividends / Interest on Equity
PU
06/18HYPERA S A : Fact Sheet 2021
PU
06/10HYPERA S A : Company, Subsidiary and affiliates Form - May
PU
06/10HYPERA S A : Consolidated Form - May
PU
05/26HYPERA S A : Annual Report
PU
05/10HYPERA S A : Consolidated Form - April
PU
05/10HYPERA S A : Company, Subsidiary and affiliates Form - April
PU
05/07HYPERA S A : Demonstrações Financeiras em Padrões Internacionais - Versão em Ing..
PU
More news
News in other languages on HYPERA S.A.
2020BOURSES ASIATIQUES : optimisme en Chine avant la réunion du G7, Tokyo sceptique
2020Tokyo replonge après un optimisme de courte durée
2020Tokyo optimiste avant la réunion du G7 sur le coronavirus
More news
Analyst Recommendations on HYPERA S.A.
More recommendations
Chart HYPERA S.A.
Duration : Period :
Hypera S.A. Technical Analysis Chart | HYPE3 | BRHYPEACNOR0 | MarketScreener
Technical analysis trends HYPERA S.A.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 37,00 BRL
Average target price 43,04 BRL
Spread / Average Target 16,3%
EPS Revisions
Managers and Directors
Breno Toledo Pires de Oliveira Chief Executive Officer & Director
Adalmario Ghovatto Satheler do Couto Chief Financial Officer & IR Officer
Álvaro Stainfeld Link Chairman
Juliana Aguinaga Damião Salem Director-Legal & Compliance
David Coury Neto Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HYPERA S.A.8.03%4 569
JOHNSON & JOHNSON9.46%453 498
ROCHE HOLDING AG13.88%339 298
PFIZER, INC.19.42%246 075
NOVARTIS AG0.14%225 528
ELI LILLY AND COMPANY46.06%224 166